NRXP
Javitt Jonathan C, NRXP's 10% owner, spent $46.8K of their own money on 40,000 shares at $1, growing their stake 90%.
+$46.8K
40,000 sh @ $1
NRXP
NRX Pharmaceuticals, Inc.
SEC CIK 1719406
$3.84
+108.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
24
Most recent
Advertisement
At a glance
Insiders at NRXP have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.
Largest recent trade: Javitt Daniel C. sold $791.4K of NRXP, trimming their stake 7%.
Most active filer: Javitt Daniel C., with 7 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for NRXP, newest firstNRXP
Gorovitz Aaron, NRXP's Director, spent $11.2K of their own money on 35,000 shares at $0, growing their stake 50%.
+$11.2K
35,000 sh @ $0
NRXP
Hurvitz Chaim, NRXP's Director, spent $20.1K of their own money on 70,000 shares at $0, growing their stake 14%.
+$20.1K
70,000 sh @ $0
NRXP
Javitt Jonathan C, NRXP's 10% owner, spent $33K of their own money on 100,000 shares at $0, growing their stake 29%.
+$33K
100,000 sh @ $0
NRXP
Javitt Jonathan C, NRXP's 10% owner, spent $64.4K of their own money on 200,000 shares at $0, growing their stake 137%.
+$64.4K
200,000 sh @ $0
Advertisement
NRXP
Willard Stephen H, NRXP's CEO, spent $58.5K of their own money on 50,000 shares at $1, opening a brand-new position.
+$58.5K
50,000 sh @ $1
NRXP
Van Voorhees Seth, NRXP's CFO, spent $33K of their own money on 30,000 shares at $1, growing their stake 184%.
+$33K
30,000 sh @ $1
NRXP
−$400K
400,000 sh @ $1
NRXP
−$12.7K
8,441 sh @ $2
NRXP
−$20.7K
13,730 sh @ $2
NRXP
Flynn Patrick John, NRXP's Director, spent $3.1K of their own money on 2,500 shares at $1, growing their stake 7%.
+$3.1K
2,500 sh @ $1
NRXP
Flynn Patrick John, NRXP's Director, spent $3.1K of their own money on 2,500 shares at $1, growing their stake 7%.
+$3.1K
2,500 sh @ $1
NRXP
Flynn Patrick John, NRXP's Director, spent $2.2K of their own money on 1,750 shares at $1, opening a brand-new position.
+$2.2K
1,750 sh @ $1
NRXP
Van Voorhees Seth, NRXP's CFO, spent $9.8K of their own money on 8,716 shares at $1, opening a brand-new position.
+$9.8K
8,716 sh @ $1
NRXP
Van Voorhees Seth, NRXP's CFO, spent $660 of their own money on 600 shares at $1, growing their stake 7%.
+$660
600 sh @ $1
NRXP
Van Voorhees Seth, NRXP's CFO, spent $7.8K of their own money on 7,021 shares at $1, growing their stake 75%.
+$7.8K
7,021 sh @ $1
NRXP
Hurvitz Chaim, NRXP's Director, spent $44.4K of their own money on 40,408 shares at $1, growing their stake 9%.
+$44.4K
40,408 sh @ $1
NRXP
Hurvitz Chaim, NRXP's Director, spent $185.5K of their own money on 171,780 shares at $1, growing their stake 60%.
+$185.5K
171,780 sh @ $1
NRXP
−$34.7K
33,018 sh @ $1
NRXP
Hurvitz Chaim, NRXP's Director, spent $284.9K of their own money on 287,812 shares at $1, opening a brand-new position.
+$284.9K
287,812 sh @ $1
NRXP
−$136.4K
133,719 sh @ $1
NRXP
−$49.5K
49,200 sh @ $1
NRXP
−$791.4K
784,063 sh @ $1
NRXP
−$0
2M sh
Advertisement
About NRXP insider activity
This page tracks every recent Form 4 filed for NRX Pharmaceuticals, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is NRXP insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for NRX Pharmaceuticals, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.